文献速递外周动脉疾病

腘动脉瘤的自然病史、生长速率与治疗:多中心回顾性队列研究

Natural history, growth rates, and treatment of popliteal artery aneurysms.
PubMed 文献 · J Vasc Surg · 2021-09-06

该多中心回顾性队列研究纳入瑞典和新西兰两个血管中心2009—2017年诊断的241例腘动脉瘤患者(397条患肢),旨在描述其诊疗轨迹与生长速率。结果显示68%患者接受治疗,择期修复多在诊断后1年内进行,小动脉瘤在急诊修复组中比例更高,生长与初始直径较大及合并腹主动脉瘤相关。

要点

  • 多数腘动脉瘤患者最终需择期修复,且常于诊断后1年内完成。
  • 较小直径腘动脉瘤仍存在不可忽视的急诊修复风险。
  • 腘动脉瘤生长与初始直径较大及合并腹主动脉瘤独立相关。

核心结论

  • 多数监测中的腘动脉瘤患者将需要择期修复,且通常在诊断后1年内进行。
  • 较小直径腘动脉瘤的急诊修复风险不可忽视,但预防性早期修复的最佳选择策略仍未知。

研究设计与样本

  • 回顾性多中心队列研究,纳入瑞典(2009—2016)和新西兰(2009—2017)两个血管中心所有腘动脉瘤患者,共241例(397条患肢)。
  • 数据来自电子病历,按患者和患肢水平分析合并症、治疗及结局,平均监测随访5.1年。
  • 治疗指征为出现急诊症状或腘动脉瘤阈值>2 cm,动脉瘤分为小(≤15 mm)和大(>15 mm)。

主要发现

  • 241例患者中156例为双侧腘动脉瘤,163例(68%)接受治疗,397条患肢中215条(54%)接受治疗。
  • 择期修复者中66%(105/158)在诊断后1年内治疗。
  • 急诊修复组小腘动脉瘤比例高于择期修复组(6/57 [11%] vs 12/158 [8%];P < .001)。
  • 择期组与急诊组平均直径无差异(30.1 mm vs 32.2 mm;P = .39)。
  • 110个腘动脉瘤记录到生长,多因素分析显示与较大初始直径(OR 1.138;95%CI 1.040-1.246;P = .005)及合并腹主动脉瘤(OR 2.553;95%CI 1.018-6.402;P = .046)相关。

关键数值与推荐

  • 治疗指征为出现急诊症状或腘动脉瘤直径>2 cm。
  • 动脉瘤大小分组阈值:小动脉瘤≤15 mm,大动脉瘤>15 mm。
  • 择期修复者中66%(105/158)在诊断后1年内接受治疗。

临床怎么用

  • 对腘动脉瘤患者应认识到多数最终需择期修复,且常于诊断后1年内发生。
  • 小直径腘动脉瘤仍需警惕急诊修复风险,不宜简单视为低危。
  • 合并腹主动脉瘤或初始直径较大的腘动脉瘤生长风险更高,可考虑更密切监测。

局限性

  • 回顾性设计可能引入选择偏倚和信息偏倚。
  • 预防性早期修复的最佳选择策略仍未确定,需未来形态学研究支持个体化监测方案。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The natural history of a cohort of patients monitored for popliteal artery aneurysms (PAAs) has not been well described. A prevailing uncertainty exists regarding the optimal surveillance strategies and timing of treatment. The primary aim of the present study was to describe the care trajectory of all patients with PAAs identified at two tertiary vascular centers, both in surveillance and eventually treated. The secondary aim was to define the PAA growth rates. METHODS: A retrospective, multicenter cohort study was performed of all patients with PAAs at two vascular centers in two countries (Sweden, 2009-2016; New Zealand, 2009-2017). Data were collected from electronic medical records regarding the comorbidities, treatment, and outcomes and analyzed on a patient- and extremity-specific level. Treatment was indicated at the occurrence of emergent symptoms or considered at a PAA threshold of >2 cm. The PAAs were divided into small (≤15 mm) and large (>15 mm) aneurysms. The mean surveillance follow-up was 5.1 years. RESULTS: Most of the 241 identified patients (397 limbs) with a diagnosis of PAAs had bilateral aneurysms (n = 156). Most patients were treated within the study period (163 of 241; 68%), and one half of the diagnosed extremities with PAA had been treated (54%; 215 of 397). Among those who had undergone elective repair, treatment had usually occurred within 1 year after the diagnosis (66%; 105 of 158). More small PAAs were detected in the group that had required emergent repair compared with elective repair (6 of 57 [11%] vs 12 of 158 [8%]; P < .001). No differences were found in the mean diameters between the elective and emergent groups (30.1 mm vs 32.2 mm; P = .39). Growth was recorded in 110 PAAs and on multivariate analysis was associated with a larger index diameter (odds ratio, 1.138; 95% confidence interval, 1.040-1.246; P = .005) and a concurrent abdominal aortic aneurysm (odds ratio, 2.553; 95% confidence interval, 1.018-6.402; P = .046). CONCLUSIONS: The present cohort of patients represented a true contemporary clinical setting of monitored PAAs and showed that most of these patients will require elective repair, usually within 1 year. The risk of emergent repair is not negligible for patients with smaller diameter PAAs. However, the optimal selection strategy for preventive early repair is still unknown. Future morphologic studies are needed to support the development of individualized surveillance protocols.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Jergovic I, Cheesman MA, Siika A, et al. Natural history, growth rates, and treatment of popliteal artery aneurysms. J Vasc Surg. 2021. PMID: 34500029. doi:10.1016/j.jvs.2021.07.243

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。